UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006411
Receipt number R000007471
Scientific Title Intralesional Cidofovir application in recurrent laryngeal papillomatosis
Date of disclosure of the study information 2011/10/04
Last modified on 2017/09/20 10:30:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intralesional Cidofovir application in recurrent laryngeal papillomatosis

Acronym

Intralesional Cidofovir application in laryngeal papillomatosis

Scientific Title

Intralesional Cidofovir application in recurrent laryngeal papillomatosis

Scientific Title:Acronym

Intralesional Cidofovir application in laryngeal papillomatosis

Region

Japan


Condition

Condition

laryngeal papillomatosis

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to determine the efficacy of intralesional injection of cidofovir in improving resolution of recurrent respiratory papillomatosis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

to determine of frequency of relapses, and size.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

recurrent laryngeal papillma

Key exclusion criteria

non recurrent laryngeal papillma

Target sample size

1


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eiji Yumoto

Organization

Kumamoto university

Division name

Otolaryngology Head & Neck Suregry

Zip code


Address

1-1-1 Honjyo, Kumamoto

TEL

096-373-7076

Email

jibika-ikyoku@kuh.kumamoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tetsuji Sanuki

Organization

Kumamoto university

Division name

Otolaryngology Head & Neck Suregry

Zip code


Address

1-1-1 Honjyo, Kumamoto

TEL

096-373-7076

Homepage URL


Email

otostl0319@kuh.kumamoto-u.ac.jp


Sponsor or person

Institute

Kumamoto university

Institute

Department

Personal name



Funding Source

Organization

non

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

熊本大学病院


Other administrative information

Date of disclosure of the study information

2011 Year 10 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 09 Month 04 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 01 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observe drug response


Management information

Registered date

2011 Year 09 Month 27 Day

Last modified on

2017 Year 09 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007471


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name